Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
T-cell lymphomas make up less than 15% of non-Hodgkin lymphomas in the United States. These lymphomas start in early forms of T lymphocytes (T cells). There are many types of T-cell lymphoma, but they are all fairly rare.
Lymphoblastic lymphoma/leukemia (also known as T cell acute lymphoblastic leukemia/lymphoma) accounts for about 1% of all lymphomas. It’s most common in teens or young adults, with males being affected more often than females. It can be thought of as either a lymphoblastic lymphoma (LBL) or a type of acute lymphoblastic leukemia (ALL), depending on how much of the bone marrow is involved (leukemias have more cancer cells in the bone marrow). The cancer cells are very early forms of T cells.
This lymphoma often starts in the thymus (a small organ behind the breastbone and in front of the heart, which is where many T cells are made) and can grow into a large tumor in the mediastinum (the area between the lungs). This can cause trouble breathing and swelling in the arms and face.
This lymphoma is fast-growing, but there is a good chance of curing it with chemotherapy if it hasn’t spread to the bone marrow when it is first diagnosed. Often, the lymphoma form of this disease is treated in the same way as the leukemia form. For more information, see Acute Lymphocytic Leukemia (Adults).
These are uncommon types of lymphoma that develop from more mature forms of T cells.
Cutaneous T-cell lymphomas (mycosis fungoides, Sezary syndrome, and others): These lymphomas start in the skin. Skin lymphomas account for about 5% of all lymphomas. To learn more, see Lymphoma of the Skin.
Adult T-cell leukemia/lymphoma: This lymphoma is caused by infection with a virus called HTLV-1. It is rare in the United States, and much more common in Japan, the Caribbean, and parts of Africa – where infection with HTLV-1 is more common. It can affect the bone marrow (where new blood cells are made), lymph nodes, spleen, liver, skin, and other organs. There are 4 subtypes:
Angioimmunoblastic T-cell lymphoma (AITL): This lymphoma accounts for about 4% of all lymphomas. It is more common in older adults. It tends to involve the lymph nodes and bone marrow, as well as the spleen or liver, which can become enlarged. People with this lymphoma usually have fever, weight loss, skin rashes, and often develop infections. This lymphoma often progresses quickly. Treatment often works at first, but the lymphoma tends to come back (recur).
Extranodal natural killer/T-cell lymphoma, nasal type: This rare type often involves the upper airway passages, such as the nose and upper throat, but it can also invade the skin, digestive tract, and other organs. It is much more common in parts of Asia and South America. Cells of this lymphoma are similar in some ways to natural killer (NK) cells, another type of lymphocyte.
Enteropathy-associated intestinal T-cell lymphoma (EATL): EATL is a lymphoma that occurs in the lining of the intestine. It is most common in the small intestine, but it can also occur in the colon. Symptoms can include severe abdominal (belly) pain, nausea, vomiting, and bleeding from the intestine.
This lymphoma occurs in some people with celiac disease (also called gluten-sensitive enteropathy). Celiac disease is an autoimmune disease in which eating gluten, a protein found mainly in wheat and barley, causes the immune system to attack the lining of the intestine and other parts of the body. This lymphoma is rare among people who have had celiac disease since childhood, but more common in people diagnosed as older adults. It is more common in men than women.
Monomorphic epitheliotropic intestinal T cell lymphoma (MEITL): This rare type of lymphoma also affects the lining of the intestines, but it is not linked to celiac disease.
Anaplastic large cell lymphoma (ALCL): About 2% of lymphomas are of this type. It is more common in young people (including children), but it can also affect older adults. This type of lymphoma tends to be fast growing, but many people with this lymphoma can be cured.
There are different forms of ALCL:
Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS): This name is given to T-cell lymphomas that don’t fit well into any of the groups above. Most people diagnosed with these lymphomas are in their 60s. These lymphomas often involve the lymph nodes, but they can also affect the skin, bone marrow, spleen, liver, and digestive tract. As a group, these lymphomas tend to spread and grow quickly. Some of these lymphomas respond well to chemotherapy, but over time they tend to become harder to treat.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Al Somali Z, Hamadani M, Kharfan-Dabaja M, et al. Enteropathy-associated T cell lymphoma. Current Hematologic Malignancy Reports. 2021;16(2):140-7. https://link.springer.com/article/10.1007/s11899-021-00634-4
Horwitz SM, Ansell S, Ai WZ, et al. 2022. T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology. JNCCN. 2022:20(3):285-308. https://doi.org/10.6004/jnccn.2022.0015
Chavez JC, Bachmeier C, and Kharfan-Dabaja MA. CAR T-cell therapy for B-cell lymphomas: Clinical trial results of available products. Therapeutic Advances in Hematology. 2019:10:2040620719841581. https://doi.org/10.1177/20406207198415
Last Revised: February 15, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.